Global Liquid Biopsy Products Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Liquid Biopsy Products Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.



This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.

According to our (Global Info Research) latest study, the global Liquid Biopsy Products market size was valued at US$ 2252 million in 2023 and is forecast to a readjusted size of USD 10510 million by 2030 with a CAGR of 24.9% during review period.

The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.

This report is a detailed and comprehensive analysis for global Liquid Biopsy Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Liquid Biopsy Products market size and forecasts, in consumption value ($ Million), 2019-2030

Global Liquid Biopsy Products market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Liquid Biopsy Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Liquid Biopsy Products market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Liquid Biopsy Products

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Liquid Biopsy Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, Menarini Silicon Biosystems, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Liquid Biopsy Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Liquid Biopsy Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
CTCs
ctDNA
Exosomes

Market segment by Application
Blood Sample
Urine Sample
Other Bio Fluids

Market segment by players, this report covers
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Liquid Biopsy Products product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Liquid Biopsy Products, with revenue, gross margin, and global market share of Liquid Biopsy Products from 2019 to 2024.

Chapter 3, the Liquid Biopsy Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Liquid Biopsy Products market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy Products.

Chapter 13, to describe Liquid Biopsy Products research findings and conclusion.